Patients with grade 2 glioma who received radiation therapy plus PCV chemotherapy experienced longer progression-free and overall survival times compared to those who received radiation therapy alone. The treatment combination improved survival rates by up to 10 years.
Researchers found improved survival rates for acute liver failure patients, with overall survival increasing from 67% to 75%, and survival without a transplant rising from 45% to 56%. Transplant success also improved, with survival rates reaching 96%.
A Swedish cohort study found that surgeons need to perform at least 15 operations to obtain stable survival results during the first months after oesophagectomy. The learning curve for achieving optimal long-term survival takes 60 operations, highlighting the importance of proper mentorship and training programs.
Research at Duke University Medical Center found that prostate cancer patients with lymph-only metastasis have the longest overall survival, while those with liver involvement fare worst. The study analyzed outcomes of 8,736 men with metastatic prostate cancer and provides valuable information on prognosis and treatment approaches.
Adherence to guideline-recommended care following in-hospital cardiac arrests (IHCA) varies significantly among US hospitals, affecting patient survival. Top-performing hospitals have higher survival rates due to timely and high-quality care.
A study published in JAMA Cardiology found significant variations in US hospital cardiac arrest care quality. Hospitals with better adherence to recommended guidelines have higher survival rates for patients treated for in-hospital cardiac arrest. The researchers estimate that an additional 22,990 to 24,200 lives could be saved annuall...
A study published in the JNCI: Journal of the National Cancer Institute found that PET scans did not improve two-year survival rates for lung and esophageal cancer patients. The researchers suggest potential overuse of PET scans in detecting recurrence, warranting efforts to decrease unnecessary utilization.
A study using nationwide population-based data found that chemoradiation therapy improves survival rates among a subset of elderly head and neck cancer patients. Patients aged 71-79 with low comorbidity scores and advanced disease stage showed a significant survival benefit from chemoradiation, while those aged 80 and above did not.
The study analyzed 10-year survival rates among European populations aged 75-84 to see if they reached 85-94 years of age. Geographical variations in old age survival rates were found, with areas like Madrid and Salamanca in Spain showing high survival rates, while Glasgow and Manchester in the UK showed low survival rates.
Researchers found African-American children and adolescents with Hodgkin lymphoma had significantly lower overall survival rates at 25 years compared to their white and Hispanic counterparts. The study, published in Pediatric Blood & Cancer, analyzed data from over 7,800 patients across Florida and the US.
A study published in the Canadian Medical Association Journal found that residents of high-rise buildings living on lower floors had better survival rates from cardiac arrests. Notably, survival was negligible for people living above the 16th floor. The researchers suggest several solutions to improve time to patient contact and increa...
Emergency physicians propose three interventions to improve cardiac arrest survival rates: developing a national OHCA registry, encouraging bystander CPR, and fostering high-performance CPR. The authors argue that inadequate research funding is a significant problem, hindering efforts to reduce mortality rates.
A Mayo Clinic study of 102 lung transplant patients found that those who were frail before surgery had lower survival rates at one and three years post-transplant. Frailty was associated with decreased survival and poorer outcomes.
The T-DM1 trial showed that the treatment increased median overall survival for heavily pretreated HER2-positive breast cancer patients by 22.7 months compared to treatment of physician's choice. The study also found reduced incidence of grade 3 or higher adverse events among those assigned T-DM1.
Studies found that patients with delayed breast cancer surgery and chemotherapy had poorer overall and disease-specific survival rates. A delay of up to 90 days in receiving chemotherapy was associated with no adverse outcomes, but prolonged delays led to increased risks of death from the disease.
A study of over 20,000 women with stage IV breast cancer found improved survival rates, especially among those who received initial breast surgery. The median survival increased from 20 to 26 months, and age, tumor size, hormone receptor status, and year of diagnosis were associated with prolonged survival.
A new study reveals that fluctuating food supplies and competition can alter survival of adult fish and cause populations to fluctuate in abundance. The research found strong interactions between the amount of food and the survival rate as well as the number of fish, with more fish leading to less survival due to competing for limited ...
A study found that socioeconomic factors like race, ethnicity, insurance status, and geographic location affect the likelihood of undergoing surgery for early-stage pancreatic cancer. Patients who underwent resection had improved disease-specific survival compared to those who did not, with regional differences in survival rates observed.
New data from clinical trials at Penn Medicine demonstrate the clinical benefits of proton therapy for patients with advanced lung, pancreatic, and spine cancers. Proton therapy has been shown to reduce toxicities and improve survival rates compared to conventional radiation therapy.
Patients with light-chain (AL) amyloidosis treated with high-dose chemotherapy and autologous stem cell transplantation have the greatest success for long-term survival. Nearly one-third of patients achieved up to 20-year survival after treatment.
A recent study published in JAMA Oncology examined cancer-care outcomes among US hospitals and found significant differences in long-term survival rates among four major categories of hospitals: PPS-exempt, NCI cancer centers, AMC, and other hospitals. The analysis revealed substantial gaps in survival rates, with patients treated at P...
A study of 173,797 female breast cancer patients found that catching cancers when they are small makes a difference to survival, even with modern therapies. Traditional factors such as tumour size and lymph node status have a significant influence on overall mortality independent of age and tumour biology.
A new clinical trial has found that cabozantinib, a second-line therapy, controls the growth of advanced kidney cancer more effectively than everolimus. The results show improved progression-free survival and lower tumor growth rates, indicating potential for prolonged survival.
A large study found that aspirin use after a cancer diagnosis significantly increases overall survival rates for patients with gastrointestinal tumours. The researchers analysed data from nearly 14,000 patients and discovered a strong association between aspirin use and improved survival.
The CheckMate 025 phase III clinical trial shows that nivolumab significantly prolongs survival in patients with advanced kidney cancer, regardless of PD-L1 expression. The study found a median overall survival of 25 months for nivolumab-treated patients compared to 19.6 months for those treated with everolimus.
The EUROCARE 5 study shows significant geographical variations in survival from blood cancers in Europe, with the highest five-year relative survival rate for Hodgkin lymphoma at 81% in Northern European countries. In contrast, chronic myeloid leukemia had a significantly lower survival rate of 53%, particularly in Eastern Europe.
A study of nearly 26,000 patients found that DNR orders were not aligned with their predicted neurological survival rates, particularly for those with the worst prognosis. Patients without DNR orders had a significantly higher rate of favorable neurological survival.
Research shows low-level oil exposure leads to later heart defects, weaker swimming, and reduced survival in Alaskan fish populations. Subtle changes in heart formation have delayed but important consequences for first-year survival, determining the long-term abundance of wild fish populations.
A study of extremely preterm infants found changes in maternal and infant care practices resulting in improved survival rates. Survival without major health problems increased significantly for infants born at 25-28 weeks.
Survival rates for extremely preterm infants have increased significantly over the past 20 years, with improvements in maternal/neonatal care leading to reduced complications and mortality. The study found that survival without major complications increased approximately 2 percent per year for infants at 25 to 28 weeks' gestation.
A study found that delayed administration of epinephrine was associated with a decreased chance of 24-hour survival and survival to hospital discharge among children with cardiac arrest. The researchers analyzed data from the Get With the Guidelines-Resuscitation registry and included U.S. pediatric patients who received at least one d...
A new analysis found that patients taking certain heart medications to manage stress may have a longer survival time than those not taking these drugs. Nonselective beta blockers showed the most significant benefit in extending median survival time, particularly among patients with hypertension.
Researchers found that generic heart medications, specifically nonselective beta-blockers, significantly improved overall survival among ovarian cancer patients. This is attributed to the ability of these drugs to block stress pathways involved in tumor growth and spread, with further research needed to explore their potential benefits.
A study published in Neurosurgery found that complete resection of high-grade brain cancer significantly improves survival rates in children. The study revealed a greater survival benefit for female patients compared to male patients. Gross total resection (GTR) improved the chances of survival free of recurrent or progressive cancer o...
A UC Davis study found that nearly one-third of ovarian cancer patients survived at least 10 years after diagnosis, contradicting the common perception of poor survival rates. The research also identified younger, earlier-stage disease and lower-risk tumor types as factors associated with longer survival.
A new Cancer Research UK study reveals that England's cancer survival rates remain lower than those of countries with similar healthcare systems, despite steady improvements. The study found five-year survival from breast cancer improved more in England than in four leading countries, but overall cancer survival was lowest in England.
The study found that regional node irradiation had a marginal impact on overall survival for patients with stage I, II, or III breast cancer. This was accompanied by improved disease-free and distant-disease-free survival rates, but long-term radiation effects remain unknown.
A new study found that increased radiation dose offers no survival benefit for patients with low-risk prostate cancer. In contrast, men with medium- and high-risk cancers saw improved survival rates with higher doses.
A three-year fishery closure around Robben Island increased African penguin chick survival rates by 18%, a significant improvement for the endangered species. The study highlights the importance of small no-take zones in improving demographic parameters of mobile species like the African penguin.
Researchers found improved median survival of patients with low-grade gliomas increasing from 44 months to 57 months between 1999 and 2010. The study suggests more effective chemotherapies contribute to the increased survival, despite a decrease in radiation therapy use.
A pooled analysis of patients with metastatic colorectal cancer (mCRC) treated with bevacizumab found that those with the lowest body mass index (BMI) had significantly shorter overall survival compared to other BMI categories. Progression-free survival was similar across all subgroups.
The five-year survival rate for Canadians with cystic fibrosis who have received a lung transplant is 67 percent, according to new research published in the Journal of Heart Lung Transplantation. Additionally, half of those who have had transplants live beyond 10 years. The study found that factors such as age at transplant and certain...
A study published in Cancer Epidemiology, Biomarkers & Prevention found that lung cancer patients with comorbidities such as chronic obstructive pulmonary disease, diabetes, or congestive heart failure had a higher risk of death. These patients also experienced poorer survival rates at each stage of the disease.
A recent study found that pre-diagnostic short sleep duration and frequent snoring are associated with significantly poorer cancer-specific survival rates among women with breast cancer. The research suggests that improving sleep patterns may motivate and empower cancer patients to enhance their survival rates.
The study found that nivolumab improved median overall survival by 2.4 months and doubled the one-year survival rate compared to chemotherapy. The immunotherapy drug also reduced the risk of dying from lung cancer by 41%.
Researchers developed a model to assess how dams affect sea-run fish populations, finding that abundance and distribution increased when mainstem dams were removed or passage efficiency improved. The model can predict ecological responses of fish populations and evaluate management actions for fish migrating between fresh and saltwater.
A phase III randomized clinical trial suggests that Stereotactic Ablative Radiotherapy (SABR) is equally effective to surgery in treating operable stage I non-small cell lung cancer patients, with better survival rates and lower toxicity. SABR appears to be a suitable alternative for elderly and comorbidity-prone patients.
A Loyola University Medical Center study found that among 205 cases of mesenchymal chondrosarcoma, more than half survived at least five years and 43 percent survived at least 10 years. Survival rates varied depending on tumor location, with axial tumors showing worse outcomes.
A study of over 1.5 million patients found a passing increase in adjusted mortality rates following Massachusetts health insurance reform, suggesting that simply providing insurance incentives and subsidies may not improve survival for trauma patients. The study's findings resolve within a few years, but highlight the need for more com...
A large cohort study found that long-term use of entecavir (ETV) or tenofovir (TDF) results in excellent 5-year survival for Caucasian patients with chronic hepatitis B (CHB), with a significant proportion of deaths coming from liver-unrelated causes. The development of hepatocellular carcinoma plays a major role in mortality.
A recent EORTC trial found that adjuvant Ipilimumab significantly improves recurrence-free survival in patients with completely resected stage III melanoma at high risk of disease recurrence. However, the treatment was also associated with a high rate of immune-related adverse events.
A study by Dartmouth-Hitchcock's Camilo Fadul and colleagues found no correlation between regulatory T cells (Tregs) and patient survival in glioblastoma. The researchers used a novel epigenetic quantitative analysis methodology to quantify lymphocyte populations, including Tregs, in tumor tissue and peripheral blood.
Researchers compared long-term survival, stroke, reoperation, and bleeding events after bioprosthetic vs mechanical prosthetic mitral valve replacement among 3,433 patients. They found no significant difference in survival at 15 years, but significant differences in risk of reoperation, bleeding, and stroke between the two groups.
Therapeutic anti-cancer vaccines have been associated with a statistically significant increase in patient survival, but rarely have a noticeable effect on tumor growth. The study suggests that overall survival, rather than progression-free survival, should be the gold standard for evaluating cancer vaccine efficacy.
A Yale University study found that higher breast cancer treatment costs are associated with better survival rates. Over a decade, Medicare costs increased from $18,100 to $32,600, while five-year survival improved from 38.5% to 51.9%. The cost increase was largely due to chemotherapy and radiation therapy.
Researchers found that young tropical forests experienced significant declines in manakin survival during dry weather associated with El Niño events. In contrast, mature forests showed stable survival rates regardless of climatic shifts, suggesting a constant abundance of fruit resources.
Patients with multiple myeloma who are diagnosed with MGUS first have better overall survival compared to those without prior knowledge. However, the study also found that patients with low M-protein concentration at MGUS diagnosis have poorer MM survival rates.
Australian researchers identified MCL-1 as a critical regulator of breast development and milk production in the mammary gland. This discovery highlights the importance of MCL-1 for all stages of breast development and lactation.
Researchers at Moffitt Cancer Center have identified a key protein signaling pathway involved in the growth and survival of brain tumor stem cells. The neurotrophin pathway controls nerve growth, survival and specialization, and inhibiting TrkB and TrkC receptors can decrease stem cell survival.
A new TGen study finds targeting stroma surrounding cancer cells can improve treatments and extend patient survival in pancreatic cancer patients. High levels of stroma correlate with poor patient survival, with median survival rates ranging from 9-24 months depending on hyaluronan and collagen levels.